hnRNPA1 couples nuclear export and translation of specific mRNAs downstream of FGF-2/S6K2 signalling.

The increased cap-independent translation of anti-apoptotic proteins is involved in the development of drug resistance in lung cancer but signalling events regulating this are poorly understood. Fibroblast growth factor 2 (FGF-2) signalling-induced S6 kinase 2 (S6K2) activation is necessary, but the downstream mediator(s) coupling this kinase to the translational response ...
is unknown. Here, we show that S6K2 binds and phosphorylates hnRNPA1 on novel Ser4/6 sites, increasing its association with BCL-XL and XIAP mRNAs to promote their nuclear export. In the cytoplasm, phosphoS4/6-hnRNPA1 dissociates from these mRNAs de-repressing their IRES-mediated translation. This correlates with the phosphorylation-dependent association of hnRNPA1 with 14-3-3 leading to hnRNPA1 sumoylation on K183 and its re-import into the nucleus. A non-phosphorylatible, S4/6A mutant prevented these processes, hindering the pro-survival activity of FGF-2/S6K2 signalling. Interestingly, immunohistochemical staining of lung and breast cancer tissue samples demonstrated that increased S6K2 expression correlates with decreased cytoplasmic hnRNPA1 and increased BCL-XL expression. In short, phosphorylation on novel N-term sites of hnRNPA1 promotes translation of anti-apoptotic proteins and is indispensable for the pro-survival effects of FGF-2.
Mesh Terms:
14-3-3 Proteins, Active Transport, Cell Nucleus, Cell Line, Cell Nucleus, Fibroblast Growth Factor 2, Gene Expression Regulation, HEK293 Cells, Heterogeneous-Nuclear Ribonucleoprotein Group A-B, Humans, Protein Biosynthesis, RNA, Messenger, Ribosomal Protein S6 Kinases, 90-kDa, Signal Transduction, Sumoylation, X-Linked Inhibitor of Apoptosis Protein, bcl-X Protein
Nucleic Acids Res.
Date: Nov. 10, 2014
Download Curated Data For This Publication
187118
Switch View:
  • Interactions 396